Skip to main content

Table 1 Two-by-two contingency table for disproportionality analysis

From: A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS)

 

Adverse events of interest

All other adverse events

Total

Drug of interest

a

b

a + b

All other drugs of interest

c

d

c + d

Total

a + c

b + d

a + b + c + d